Deep learning–based tumour segmentation and total metabolic tumour volume prediction in the prognosis of diffuse large B-cell lymphoma patients in 3D FDG-PET images
- 15 February 2022
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 32 (7) , 4801-4812
Abstract
Objectives To demonstrate the effectiveness of automatic segmentation of diffuse large B-cell lymphoma (DLBCL) in 3D FDG-PET scans using a deep learning approach and validate its value in prognosis in an external validation cohort. Methods Two PET datasets were retrospectively analysed: 297 patients from a local centre for training and 117 patients from an external centre for validation. A 3D U-Net architecture was trained on patches randomly sampled within the PET images. Segmentation performance was evaluated by six metrics, including the Dice similarity coefficient (DSC), Jaccard similarity coefficient (JSC), sensitivity (Se), positive predictive value (PPV), Hausdorff distance 95 (HD 95), and average symmetric surface distance (ASSD). Finally, the prognostic value of predictive total metabolic tumour volume (pTMTV) was validated in real clinical applications. Results The mean DSC, JSC, Se, PPV, HD 95, and ASSD (with standard deviation) for the validation cohort were 0.78 ± 0.25, 0.69 ± 0.26, 0.81 ± 0.27, 0.82 ± 0.25, 24.58 ± 35.18, and 4.46 ± 8.92, respectively. The mean ground truth TMTV (gtTMTV) and pTMTV were 276.6 ± 393.5 cm3 and 301.9 ± 510.5 cm3 in the validation cohort, respectively. Perfect homogeneity in the Bland–Altman analysis and a strong positive correlation in the linear regression analysis (R2 linear = 0.874, p < 0.001) were demonstrated between gtTMTV and pTMTV. pTMTV (≥ 201.2 cm3) (PFS: HR = 3.097, p = 0.001; OS: HR = 6.601, p < 0.001) was shown to be an independent factor of PFS and OS. Conclusions The FCN model with a U-Net architecture can accurately segment lymphoma lesions and allow fully automatic assessment of TMTV on PET scans for DLBCL patients. Furthermore, pTMTV is an independent prognostic factor of survival in DLBCL patients. Key Points •The segmentation model based on a U-Net architecture shows high performance in the segmentation of DLBCL patients on FDG-PET images. •The proposed method can provide quantitative information as a predictive TMTV for predicting the prognosis of DLBCL patients.Keywords
Funding Information
- National Nature Science Foundation of China (No.62106101)
- Jiangsu Provincial Key R&D Program (No. BE2020620, No.BE2020723)
- Natural Science Foundation of Jiangsu Province (No.BK20210180)
This publication has 25 references indexed in Scilit:
- A survey on deep learning in medical image analysisMedical Image Analysis, 2017
- Prognostic significance of total metabolic tumor volume on 18F-fluorodeoxyglucose positron emission tomography/ computed tomography in patients with diffuse large B-cell lymphoma receiving rituximab-containing chemotherapyOncotarget, 2017
- Deep Learning in Medical Image AnalysisAnnual Review of Biomedical Engineering, 2017
- DeepLab: Semantic Image Segmentation with Deep Convolutional Nets, Atrous Convolution, and Fully Connected CRFsIEEE Transactions on Pattern Analysis and Machine Intelligence, 2017
- The Importance of Skip Connections in Biomedical Image Segmentation2016
- Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCLEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewMolecular Cancer, 2015
- Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993